Nevertheless, Ramasubbu and Devi Rajeswari [32] indicated that RAGE may inhibit the mammalian target of rapamycin (mTOR) and phosphatidyl inositol 3-kinase-AKT (PI3K/AKT) signaling pathways during diabetes. This evidence concerns the gene AKT1 and diabetes mellitus.